April 2021

NEWS & COLUMNS

6-7 NEWS
Oxford University’s malaria vaccine is 77% effective; Retevmo shows early promise in new cancer types

8-11 CORONAVIRUS NEWS
J&J resumes US roll out of COVID-19 vaccine; EU begins legal action against AstraZeneca

12 DARWIN'S MEDICINE
Cross functions – the biggest problem in your company is also your biggest opportunity

13 POLICY AND PUBLIC HEALTH
The technology responses to this pandemic have fallen far short of expectations

14 SENSE OF BELONGING
Achieving a good sense of belonging in your teams increases productivity and reduces turnover

15 PHARMA MARKETERS' BLOG
On your marks, get set...brand plan!

FEATURES

16-17 RARE DISEASES: WHY THEY
CAN BE SO DIFFICULT TO IDENTIFY
Symptoms shared with more common diagnoses can make them more difficult to spot

18-19 THE LESSONS LEARNED
FROM COVID-19’S IMPACT
ON ONCOLOGY TRIALS
How COVID-19’s lasting legacy will reshape clinical cancer research

20-21 PILOTING A ROUTE
TO THE BIOSIMILARS
OPPORTUNITIES IN EUROPE
Investigating the EU regulatory hurdles that life sciences companies face

24-25 ALZHEIMER’S DISEASE:
THE SEARCH FOR A CURE
To ensure the successful discovery and development of new dementia therapies, key gaps in the field need to be addressed